EnVivo Announces Hiring of Vice President of Chemistry

EnVivo Announces Hiring of Vice President of Chemistry
Watertown, MA – August 16, 2004 – EnVivo Pharmaceuticals, Inc. announced today the addition to its Management Team of Gideon Shapiro, Ph.D., as Vice President of Chemistry.

Gideon Shapiro is a medicinal chemist who brings 18 years of research and management experience in large pharmaceutical and biotech environments to EnVivo Pharmaceuticals. Gideon spent 12 years at Sandoz/Novartis Pharmaceuticals in Basel, Switzerland in various functions, acting ultimately as co-manager of the Neurodegeneration Research Department at Sandoz. Subsequently he was co-founder and CEO of the genomics company EraGen Biosciences and founder and CSO of Somatocor Pharmaceuticals. He received his Ph.D. in organic chemistry in 1984 from the University of California at Berkeley and performed postdcoctoral research at the Federal Institute of Technology (ETH) in Zurich, Switzerland before joining Sandoz. He is the co-author of numerous publications and patents in organic synthesis, medicinal chemistry, peptide chemistry and pharmacology and taught for the graduate seminar program at the University of Basel, Switzerland.

“We are extremely pleased to welcome Gideon Shapiro to the EnVivo management team. The addition of Gideon as VP of Chemistry strengthens EnVivo’s ability to discover and develop small molecule therapeutics for CNS disorders and is an important addition to our already strong team.” said David Lowe, Ph.D., President and CEO of EnVivo.

About EnVivo: EnVivo Pharmaceuticals (located in Watertown, MA) is a biopharmaceutical company dedicated to discovering and developing drugs for central nervous system (CNS) disorders currently focusing on Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease, and Spinocerebellar ataxias. The company has created a new paradigm in drug discovery using a proprietary screening platform based on humanized Drosophila disease models to rapidly identify hits that are then tested in vertebrate assays. For more information about EnVivo, please visit www.envivopharma.com.

For additional information, please contact:
Media Relations
Tel: 617-563-5800